There are more than ten thousand listed companies in Europe and North America, and a startling share of them trade every day without a single professional forming an independent opinion about what they are worth. Investors have a name for these firms — orphan stocks — and the consequences of that orphanhood are no longer a matter of speculation, because a growing body of evidence, examined in a recent analysis of how losing one analyst reprices an entire company, shows that the disappearance of even a single covering analyst measurably raises a firm's cost of capital, shrinks its investment, and increases its odds of a credit event. The orphanage, in other words, charges rent. And it is expanding faster than most boards realize.
A Natural Experiment Nobody Designed
The reason we can speak about this with confidence rather than anecdote is an accident of market structure. Whenever a brokerage house collapses or is absorbed by a rival, every stock its analysts followed loses coverage simultaneously — healthy companies and struggling ones alike, for reasons that have nothing to do with any of them. That randomness turns broker failures into a laboratory. François Derrien and Ambrus Kecskés exploited it in a landmark study published in The Journal of Finance, tracking firms that lost an analyst this way against nearly identical firms that did not. The orphaned companies subsequently cut investment by 1.9 percent of total assets and external financing by 2.0 percent. Nothing about their operations had changed. The only thing that vanished was a person paid to understand them.
The mechanism is information asymmetry, the oldest tax in finance. Markets do not price what a company is; they price what can be verified about it. An analyst who rebuilds a firm's model every quarter, interrogates its management, and publishes estimates is a verification machine. Remove the machine and uncertainty rises — and uncertainty is never free. It shows up as wider spreads, weaker valuations, and lenders demanding extra basis points for lending into the dark. Follow-up work by the same authors found that quasi-random coverage losses pushed borrowing costs up by roughly 25 basis points and made defaults and other credit events far more likely relative to control firms.
The Cruel Geometry of Coverage
What makes these findings genuinely alarming is how coverage is distributed. The largest global corporations attract two or three dozen analysts apiece, each adding almost nothing to a mountain of existing scrutiny. Meanwhile the typical small-cap company gets by on a handful, and thousands of micro-caps subsist on one analyst or none. The marginal value of research is highest exactly where the supply is thinnest — an inversion that no market force seems able to correct, because sell-side research is ultimately funded by trading and banking revenue that small companies simply cannot generate.
Regulation then stress-tested this fragile arrangement. When Europe forced asset managers in 2018 to pay for research as an explicit line item rather than bundling it into trading commissions, research budgets contracted by an estimated 20 to 30 percent. The academic verdict on who bore the damage is genuinely contested — several studies found the cull concentrated among redundant large-cap analysts — but the assessment published by ESMA, the European Union's own securities regulator, contains the sentence that should linger: small and medium-sized companies remain structurally characterized by less research, lower-quality research, and a persistently higher probability of losing coverage altogether. The reform, on the regulator's reading, neither caused the desert nor irrigated it. Brussels was sufficiently unsettled to partially reverse its own rules for companies under €1 billion in market value — and subsequent research found that investment firms have barely used the exemption. The desert, once formed, does not refill on its own.
Living Without a Witness
For the companies stranded there, the practical question is what substitutes for a professional witness. The honest answer is: nothing fully, but several things partially. The evidence and market practice converge on a short list of survival behaviors that separate the orphans the market can still price from the ones it abandons entirely:
- Disclosure engineered for modeling — segment-level numbers, margins, and explicit guidance that a portfolio manager can use directly, because no intermediary will translate the filings anymore.
- Rhythm over volume — a fixed, predictable reporting cadence, since irregular silence from an uncovered firm is invariably read as concealment.
- Simultaneous, machine-readable distribution — announcements that land in terminals and screening databases at once, in formats algorithms can parse, because an ever-larger share of small-cap discovery is quantitative rather than human.
- Deliberate forward-looking content — the studies of post-unbundling behavior show that price reactions attach overwhelmingly to statements about the future, precisely the material that departed analysts once supplied.
Some issuers go further and commission sponsored research to restore a human voice, an arrangement that carries its own credibility discount but is increasingly treated as a cost of being small and public.
The Bill Arrives Either Way
Step back and the picture is uncomfortable in a way that transcends any single regulation. Public markets are supposed to be engines of information aggregation, yet the professional workforce that feeds those engines has been retreating from the small end of the market for two decades, and every credible measurement says the retreat imposes real costs — foregone investment, dearer debt, elevated default risk — on firms that did nothing wrong except become uninteresting to intermediaries. Being examined, it turns out, was never free; it was merely bundled. Now the bundle is gone, the invoice is visible, and the companies that refuse to pay it in deliberate, relentless self-disclosure will pay it instead in valuation. The market has stopped watching. It has not stopped charging.
Top comments (0)